HistoSonics
The Market Development Manager will expand the company's commercial presence by identifying and developing new hospital and health‑system opportunities across the Southeast region. This hunter role involves building relationships with physicians and administrators, partnering with capital sales teams, and managing a robust pipeline to drive adoption of the histotripsy technology.
HistoSonics® is a medical technology company that has developed a non-invasive, sonic beam therapy platform using histotripsy — a novel form of focused ultrasound — capable of mechanically destroying and liquefying targeted liver tumors at a sub-cellular level. The company's Edison™ System has received CE Mark approval in Europe and is pursuing FDA clearance for kidney tumors. HistoSonics' mission is to advance histotripsy and bring its benefits to physicians and patients worldwide.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for HistoSonics.
21% above the average for this role